SCHEMBL10594698

SCHEMBL10594698

CC(C)(CNC(=O)CCCO[N+](=O)[O-])NCC(O)COc1cccc2c1CCCC2=O

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 11/20 0.61
▸ ADRB1 P08588 9/20 0.61
▸ ADRB3 P13945 3/20 0.61
▸ HTR1A P08908 3/20 0.61
▸ SLC6A4 P31645 3/20 0.61
▸ TSHR P16473 1/20 0.61
▸ SIGMAR1 Q99720 1/20 0.61
▸ ABCB1 P08183 2/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ CASR P41180 2/20 0.37
▸ SLC6A2 P23975 2/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10592480 0.84 ABCB1 (0.42) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10594588 0.83 CYP2D6 (0.45) ADRB2ADRB1ADRB3CASRCYP2D6
SCHEMBL10593574 0.82 ABCB1 (0.42) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10505401 0.82 ADRB2 (0.40) ADRB2ADRB1ADRB3CASR
SCHEMBL10592061 0.82 CASR (0.50) ADRB2ADRB1ADRB3CASR
SCHEMBL10592879 0.81 HTR1A (0.61) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10504355 0.81 ADRB2 (0.37) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10595545 0.81 HTR1A (0.42) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10503937 0.80 HTR1A (0.56) ADRB2ADRB1ADRB3HTR1ASLC6A4
SCHEMBL10504192 0.80 ADRB2 (0.37) ADRB2ADRB1ADRB3HTR1ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback